NCT04387435View on ClinicalTrials.gov

Optimization of VNS in Epileptic Patients to Induce Cardioprotection

NACompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

July 7, 2021

Study Completion Date

July 7, 2021

Conditions
EpilepsySudden Cardiac Death
Interventions
OTHER

A change or titration in the current or frequency settings of the VNS therapy system.

The study treatment involves changing the output current or frequency of the default device settings in a FDA approved device for VNS therapy. The proposed frequency changes in this study are within the FDA approved output current and frequency levels.

Trial Locations (1)

90095

UCLA Health, Los Angeles

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

University of California, Los Angeles

OTHER

NCT04387435 - Optimization of VNS in Epileptic Patients to Induce Cardioprotection | Biotech Hunter | Biotech Hunter